Blog

Biden Administration Prepares Way For Banks To Refuse Service To Democrats’ Enemies

Amongst the record-breaking number of executive actions taken by President Joe Biden was one related to a little-known, frightening Obama-era program called Operation Choke Point. The program, dubbed so under former Attorney General Eric Holder, uses the power of the federal government to target legal yet leftist-disfavored businesses. These include gun sellers, pawnshops, and short-term money lenders.

The Trump administration did its best to end this blatantly unconstitutional program that sought to discriminate against legal industries. In 2017, the Justice Department declared the program “formally over.” At the end of Trump’s term, the Office of the Comptroller of the Currency established the Fair Access rule to solidify its culmination.

But on Jan. 28, the Office of the Comptroller of the Currency under President Biden announced it would pause the Trump-era rule intended to prevent another Operation Choke Point from happening again.

Keep reading

US Life Expectancy Grew in 2020 Showing Negligent Effects of China Coronavirus — US Death Rate Shows Lowest Growth in 9 Years Despite COVID Hysteria

The US life expectancy rate actually grew in 2020.
This means you can expect to live longer despite the hysteria of the China Coronavirus.

United States – Historical Life Expectancy Data

Year Life Expectancy Growth Rate
2021 78.99 0.080%
2020 78.93 0.080%
2019 78.87 0.080%
2018 78.81 -0.030%

The US Historical death rate in the United States was the lowest in 9 years.

Keep reading

Democrats’ SAFE TECH Act Could ‘Destroy Most of the Open Web’

A newly-proposed change to Section 230 would introduce legal liability for online platforms and forums for third-party speech. It is being suggested as a way of combating alleged racial and social online injustices. According to critics, however, the bill is ill-conceived and has the potential to transform large parts of the internet for the worse and empower powerful players against smaller competitors.

Section 230 has become a hot topic in the US in recent years. Under this law, which “defined how the Internet works”, platforms adopting a hands-off approach to content moderation cannot be held reliable for harmful or illegal third-party content hosted by them. The protections under the law do not extend to sites which filter users’ submissions and curate content featured on the page. As the Washington Post recounts, the Section was created in the wake of two lawsuits in the 1990s – against Prodigy Services and against CompuServe – coming to similar conclusions.

The provision has come under criticism from both Democratic and Republican legislators, albeit for different reasons. The goal of Republicans, including former president Trump, was to address selective political censorship which has been repeatedly alleged against Silicon Valley online platforms. For example, in December last year, Trump attempted to use his veto power over a proposed defence bill as leverage against the Congress to outright repeal Section 230. 

On the other hand, critics of the law among the Democrats have been blaming social media platforms for being reluctant or slow to remove content deemed as harmful, from hostile communication perceived as harassment to the spread of unreliable information. 

Keep reading

Newsweek ‘Fact Check’ Claims India Vaccine Ban “Mostly False” While Admitting De Facto Ban

Newsweek published a “fact check” which labeled claims that India had banned the Pfizer-BioNTech vaccine as “mostly false” despite admitting in the article that India has in fact temporarily banned the vaccine.

Last week, discussion around the issue intensified after it was revealed that Indian health authorities had refused to give permission for the vaccine to be distributed.

“On February 3, 2021, India’s Subject Expert Committee (SEC), a panel that advises the nation’s Central Drugs Standard Control Organisation (CDSCO), a national regulatory body focused on pharmaceuticals and devices, ruled that the Pfizer-BioNTech vaccine should not be recommended for an EUA in the country “at this stage,” reports Newsweek.

The report quotes India’s Subject Expert Committee (SEC), which ruled, “The committee noted that incidents of palsy, anaphylaxis and other SAE’s have been reported during post marketing and the causality of the events with the vaccine is being investigated. Further, the firm has not proposed any plan to generate safety and immunogenicity data in Indian population.”

In response, after the meeting with the regulator, Pfizer Inc. withdrew its application for the vaccine’s use in India.

Keep reading